Two Experimental Drugs Aimed At Controlling Viral Loads Among HIV-Positive People Who Have Developed Drug Resistance Show Promise, Researchers Say

... Two experimental antiretroviral drugs, called TMC278 and elvitegravir, show promise in controlling the viral loads of HIV-positive people who have developed resistance to available drugs, researchers said Wednesday at the 14th Annual Conference on Retroviruses and Opportunistic Infections in Los Angeles, the Los Angeles Times reports (Chong, Los Angeles Times, 3/1). [click link for full article] ...